Affordable Access

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Authors
  • Kiss, Oliver C.C.;
  • Scott, Peter J.H.;
  • Behe, Martin;
  • Penuelas, Ivan;
  • Passchier, Jan;
  • Rey, Ana;
  • Patt, Marianne;
  • Aime, Silvio;
  • Jalilian, Amir;
  • Laverman, Peter;
  • Cheng, Zhen;
  • Chauvet, Alain Faivre;
  • Engle, Jonathan;
  • Cleeren, Frederik; 86407;
  • Zhu, Hua;
  • Vercouillie, Johnny;
  • van Dam, Michael;
  • Zhang, Ming Rong;
  • Perk, Lars;
  • Guillet, Benjamin;
  • And 1 more
Publication Date
Mar 23, 2023
Source
Lirias
Keywords
License
Green
External links

Abstract

BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. MAIN BODY: This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field, and include new PET-labelling methods for 11C and 18F, the importance of choosing the proper chelator for a given radioactive metal ion, implications of total body PET on use of radiopharmaceuticals, legislation issues and radionuclide therapy including the emerging role of 161Tb. / status: published

Report this publication

Statistics

Seen <100 times